Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms

Published:2017-04-19 Issue:4 Volume:12 Page:e0173548
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lu Yin,Figler Bryan,Huang Hong,Tu Yi-Cheng,Wang Ju,Cheng Feng

Funder

National Natural Science Foundation of China

Ed and Ethel Moore Alzheimer's Disease Research Program of Florida Department of Health

National Institute of General Medical Sciences

National Natural Science Foundation of China (CN)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network;J Huang;PLoS computational biology,2013

2. Informatics confronts drug-drug interactions;B Percha;Trends Pharmacol Sci,2013

3. Drug interaction studies: study design, data analysis, and implications for dosing and labeling;SM Huang;Clinical pharmacology and therapeutics,2007

4. Drug-drug interactions—a preventable patient safety issue?;J Strandell;British journal of clinical pharmacology,2008

5. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review;ML Becker;Pharmacoepidemiology and drug safety,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between warfarin usage and international normalized ratio increase: systematic analysis of FDA Adverse Event Reporting System (FAERS);The Journal of Cardiovascular Aging;2023-10-17

2. Global epidemiology of breast cancer based on risk factors: a systematic review;Frontiers in Oncology;2023-10-10

3. Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System;Journal of Alzheimer's Disease;2022-09-13

4. Literature-based drug–drug similarity for drug repurposing: impact of Medical Subject Headings term refinement and hierarchical clustering;Future Medicinal Chemistry;2022-09

5. Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir;Biomedicine & Pharmacotherapy;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3